Annual Meets
Welcome to Next Gen Bio Tech 2026
Next Gen Bio Tech 2026, organized by Annual Meets, brings together global researchers, scientists, and industry pioneers to explore the future of biotechnology and life sciences. AI, genomics, and bioengineering, this international webinar highlights innovations driving precision medicine, therapeutic discovery, and sustainable bio-innovation. Join us to connect with thought leaders, share pioneering ideas, and shape the next generation of biotechnology — where data meets discovery and science transforms lives.
CALL FOR ABSTRACTS — Next Gen Bio Tech 2026
Theme: “Integrating AI, Bioengineering, and Genomics for Tomorrow’s Medicine
Organized by: Annual Meets in association with NEO-ART Excellence Hub Pvt. Ltd.
We are pleased to invite researchers, academicians, industry professionals, and innovators to submit abstracts for Next Gen Bio Tech 2026
- 5 selected finalists will deliver a 10-minute live presentation during the Scientific Session on January 20th engaging directly with international experts and peers.
- All finalist presentations will be recorded and featured in our event replay library for global access.
- One Best Abstract Award will be presented , recognizing outstanding innovation and impact.
- All submitted abstracts will be featured in the official event compendium, ensuring visibility across our global network — even if not selected for live presentation.
Media Partners
MARKET ANALYSIS
The biotechnology industry is experiencing unprecedented global growth, driven by rapid advancements in genomics, bioengineering, and precision medicine. Valued at approximately USD 1.77 trillion in 2024, the global biotechnology market is projected to reach nearly USD 5.7 trillion by 2034, growing at a CAGR of around 13.9%. This surge is fueled by expanding applications of genetic research, synthetic biology, and biopharmaceutical development, along with the rising demand for sustainable and personalized healthcare solutions. Within this spectrum, the regenerative medicine segment—including gene therapy, cell therapy, and tissue engineering—is anticipated to grow from USD 40 billion in 2024 to over USD 90 billion by 2030. Emerging markets in Asia-Pacific and Latin America are witnessing increased R&D investment and infrastructure expansion, complementing strong market leadership in North America and Europe. Next Gen Bio Tech 2026 stands at the forefront of this transformation, offering a global platform for researchers, industry leaders, and innovators to explore the next wave of biotech breakthroughs shaping the future of health, sustainability, and technology.